SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-000792
Filing Date
2022-01-12
Accepted
2022-01-12 16:01:14
Documents
16
Period of Report
2022-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20220111_8k.htm   iXBRL 8-K 50964
2 EXHIBIT 10.1 ex_323104.htm EX-10.1 193365
3 EXHIBIT 99.1 ex_323105.htm EX-99.1 16753
8 arp01.jpg GRAPHIC 8450
  Complete submission text file 0001437749-22-000792.txt   459373

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acrx-20220107.xsd EX-101.SCH 3593
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20220107_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20220107_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20220107_pre.xml EX-101.PRE 11584
10 EXTRACTED XBRL INSTANCE DOCUMENT acrx20220111_8k_htm.xml XML 2572
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 22526616
SIC: 2834 Pharmaceutical Preparations